Letter from the Editor

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Agile Transformation

By definition change is hard, and anyone who works for a large or even a small company has been through at least one reorganization. The agility that companies will need to compete in the new economy, one defined by the digitization of healthcare, cannot be underestimated, and requires previously unexperienced reorganization of priorities and processes.

A recent Cognizant report finds that 75% of companies already have at least one business function or process that has been impacted by digital transformation. There are several driving factors pushing companies to achieve their objectives: improving the customer experience (67%) and increasing revenue (66%), which they rank above other important elements such as increasing employee productivity (60%), driving business agility (52%), and reducing operating costs (47%). Yet, fewer than 40% of companies have aligned internal teams to put the customer at the forefront of their activities.

In a recent research project across a range of industries, including technology, only 4% of some 2,500 companies surveyed had reached enterprise agility. More and more companies are becoming overwhelmed with the increasing need to enhance customer-centricity, speed, growth, efficiency, and employee engagement — all in parallel. McKinsey analysts say leaders will need new capabilities to build 21st century organizations.

On transforming the organization, McKinsey notes several takeaways for leaders. They need to:

• Cocreate a deeply resonant organizational purpose with participation across the organization, then broadcast it at every opportunity.

• Explore a holistic new agile design for their organization, creating it as a network of empowered microbusinesses supported by a lean backbone, working in tight collaboration with external partners.

• Shape a new agile organization culture within their organization through personally modeling, and developing in others, new mind-sets and behaviors; fostering understanding and conviction around your core purpose; and ensuring the new agile design reinforces the new mindsets and behaviors.

• Engage people across the organization in cocreating the new agile organization design and culture through constant experimentation and learning.

For this month’s cover story we tapped into the C-suites of companies traversing the life-sciences industry to understand how they are executing an agile transformation.
When we asked them to evaluate their companies based on the five agility trademarks — North Star mentality, scalable team structure, rapid decision-making mentality, dynamic people model, and adoption of next-generation technologies — our C-suite executives, in general, report they are trending toward being completely agile versus being cemented in the traditional model. These same executives rate their organization favorably in terms of digital readiness. We hope you enjoy learning more about agile transformation and how leaders are steering their organizations to success for the digital age.

Taren Grom, Editor


Their Word …

Denise Myshko
Managing Editor

Dagmar Rosa-Björkeson, chief strategy and corporate development officer, Mallinckrodt Pharmaceuticals, inspired more than 100 women from all aspects of science, technology, engineering, and math at the annual Inspiring Women in STEM..

Robin Robinson
Senior Editor

Life sciences companies are increasing their use of AI for a range of processes, including drug discovery and pharmacovigilance to improving healthcare provider and patient outcomes.

Kim Ribbink
Features Editor

Rare disease patients and caregivers face a multitude of challenges, including cost, treatment options, as well as having their story understood by the medical community.


Coming in March 2019

Small Data Marketing
Wearables & Clinical Trials
Instagram & the Industry
Showcase: Brand Building
Showcase: Market Research



The forum for the industry executive

Volume 19 • Number 2
Publisher Lisa Banket
Editor Taren Grom
Creative Director Marah Walsh

Managing Editor
Denise Myshko

Senior Editor
Robin Robinson

Features Editor
Kim Ribbink

Design Associate
Ariel Medel

Director of Sales
Cathy Tracy

National Account Manager
Suzanne Besse

Webcast Network Producer
Daniel Limbach

Circulation Assistant
Kathy Deiuliis

Copyright 2019
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Nineteen, Number Two

PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by ­Pharma­­Linx LLC, P.O. Box 327, Titusville, NJ 08560. ­Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVOICE, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com.

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: mwalsh@pharmavoice.com.

Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVoice: To advertise in Pharma­­Voice please contact our Advertising ­Department at P.O. Box 327, Titusville, NJ 08560, or ­telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com.

Posted in:

Post a Comment

You must be logged in to post a Comment.